CH0509752H1 - - Google Patents

Info

Publication number: CH0509752H1
Authority: CH; Switzerland
Prior art keywords: beta; treatment; adrenergic; combinations; image
Prior art date: 1991-04-17

Application number

CH92303330T

Other languages

English (en)

Inventor

John J Baldwin

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-17

Filing date

1992-04-14

Publication date

2012-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH0509752(H1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-04-14 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2012-11-30 Publication of CH0509752H1 publication Critical patent/CH0509752H1/fr

Links

239000002876 beta blocker Substances 0.000 abstract 2
229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 1
206010030043 Ocular hypertension Diseases 0.000 abstract 1
239000003489 carbonate dehydratase inhibitor Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CH92303330T 1991-04-17 1992-04-14 CH0509752H1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US68671891A	1991-04-17	1991-04-17
US83491392A	1992-02-13	1992-02-13

Publications (1)

Publication Number	Publication Date
CH0509752H1 true CH0509752H1 (fr)	2012-11-30

Family

ID=27103852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH92303330T CH0509752H1 (fr)	1991-04-17	1992-04-14

Country Status (24)

Country	Link
EP (1)	EP0509752B1 (fr)
JP (1)	JP2527513B2 (fr)
KR (1)	KR920019348A (fr)
CN (1)	CN1073421C (fr)
AT (1)	ATE182787T1 (fr)
AU (1)	AU648659C (fr)
CA (1)	CA2065965C (fr)
CH (1)	CH0509752H1 (fr)
CY (1)	CY2146B1 (fr)
CZ (1)	CZ285129B6 (fr)
DE (3)	DE69229688T4 (fr)
DK (1)	DK0509752T3 (fr)
ES (1)	ES2133304T3 (fr)
GR (1)	GR3031467T3 (fr)
IE (1)	IE921240A1 (fr)
IL (1)	IL101537A (fr)
LU (1)	LU90506I2 (fr)
MX (1)	MX9201785A (fr)
NL (1)	NL990041I2 (fr)
NO (1)	NO306196B1 (fr)
RO (1)	RO113612B1 (fr)
SK (1)	SK282039B6 (fr)
WO (1)	WO1992018124A1 (fr)
YU (1)	YU39392A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5932572A (en) *	1992-02-21	1999-08-03	Alcon Laboratories, Inc.	Topical anti-glaucoma compositions
EP0625903B1 (fr) *	1992-02-21	1998-08-12	Alcon Laboratories, Inc.	Compositions antiglaucome a usage local comprenant des inhibiteurs d'anhydrase carbonique et de beta-bloquants
US6071904A (en) *	1996-12-11	2000-06-06	Alcon Laboratories, Inc.	Process for manufacturing ophthalmic suspensions
FI981473L (fi) *	1998-06-25	1999-12-26	Orion Yhtymae Oyj	Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en)	2001-05-31	2008-07-01	Allergan Inc	Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) *	2004-01-19	2007-10-31	无锡杰西医药科技有限公司	乙酰唑胺滴眼液
US8211450B2 (en) *	2010-05-05	2012-07-03	Senju Usa, Inc.	Ophthalmic composition
US9061034B2 (en)	2010-07-29	2015-06-23	Allergan, Inc.	Preservative free bimatoprost and timolol solutions
US9078854B2 (en)	2010-07-29	2015-07-14	Allergan, Inc.	Preservative free bimatoprost and timolol solutions
JP5893204B1 (ja) *	2015-02-23	2016-03-23	参天製薬株式会社	防腐効果のある医薬の組合せ
TW201726127A (zh) *	2016-01-29	2017-08-01	參天製藥股份有限公司	含有多佐胺、高分子及硼酸之醫藥組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4863922A (en) *	1984-12-12	1989-09-05	Merck & Co., Inc.	Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

1992
- 1992-04-09 CZ CZ932098A patent/CZ285129B6/cs not_active IP Right Cessation
- 1992-04-09 IL IL101537A patent/IL101537A/xx not_active IP Right Cessation
- 1992-04-09 RO RO93-01388A patent/RO113612B1/ro unknown
- 1992-04-09 SK SK1103-93A patent/SK282039B6/sk not_active IP Right Cessation
- 1992-04-09 WO PCT/US1992/002903 patent/WO1992018124A1/fr not_active Ceased
- 1992-04-14 CA CA002065965A patent/CA2065965C/fr not_active Expired - Lifetime
- 1992-04-14 DE DE69229688T patent/DE69229688T4/de not_active Expired - Lifetime
- 1992-04-14 EP EP92303330A patent/EP0509752B1/fr not_active Expired - Lifetime
- 1992-04-14 DK DK92303330T patent/DK0509752T3/da active
- 1992-04-14 AT AT92303330T patent/ATE182787T1/de active
- 1992-04-14 CH CH92303330T patent/CH0509752H1/fr unknown
- 1992-04-14 DE DE69229688A patent/DE69229688C5/de not_active Expired - Lifetime
- 1992-04-14 ES ES92303330T patent/ES2133304T3/es not_active Expired - Lifetime
- 1992-04-14 DE DE2000175002 patent/DE10075002I2/de active Active
- 1992-04-15 YU YU39392A patent/YU39392A/sh unknown
- 1992-04-15 MX MX9201785A patent/MX9201785A/es unknown
- 1992-04-16 AU AU14979/92A patent/AU648659C/en not_active Expired
- 1992-04-16 CN CN92103682A patent/CN1073421C/zh not_active Expired - Lifetime
- 1992-04-16 KR KR1019920006335A patent/KR920019348A/ko not_active Ceased
- 1992-04-16 IE IE124092A patent/IE921240A1/en not_active IP Right Cessation
- 1992-04-17 JP JP4097956A patent/JP2527513B2/ja not_active Expired - Lifetime
1993
- 1993-10-15 NO NO933714A patent/NO306196B1/no not_active IP Right Cessation
1999
- 1999-10-08 GR GR990402558T patent/GR3031467T3/el unknown
- 1999-12-01 NL NL990041C patent/NL990041I2/nl unknown
- 1999-12-29 CY CY9900045A patent/CY2146B1/xx unknown
2000
- 2000-01-19 LU LU90506C patent/LU90506I2/fr unknown

Also Published As

Publication number	Publication date
CA2065965C (fr)	1998-06-16
GR3031467T3 (en)	2000-01-31
ES2133304T3 (es)	1999-09-16
NO306196B1 (no)	1999-10-04
DE10075002I2 (de)	2004-07-01
IL101537A0 (en)	1992-12-30
CZ209893A3 (en)	1994-06-15
MX9201785A (es)	1992-10-01
DE69229688D1 (de)	1999-09-09
SK282039B6 (sk)	2001-10-08
NO933714L (no)	1993-10-15
CN1073421C (zh)	2001-10-24
WO1992018124A1 (fr)	1992-10-29
DE10075002I1 (de)	2000-03-30
JPH05117167A (ja)	1993-05-14
IL101537A (en)	1997-11-20
DE69229688T2 (de)	2000-02-24
DE69229688T4 (de)	2010-08-19
SK110393A3 (en)	1994-02-02
JP2527513B2 (ja)	1996-08-28
RO113612B1 (ro)	1998-09-30
NL990041I1 (nl)	2000-02-01
KR920019348A (ko)	1992-11-19
NL990041I2 (nl)	2000-04-03
ATE182787T1 (de)	1999-08-15
DE69229688C5 (de)	2010-10-21
AU1497992A (en)	1992-10-22
YU39392A (sh)	1995-12-04
EP0509752A3 (en)	1993-03-03
HK1009251A1 (en)	1999-05-28
AU648659C (en)	2008-02-14
CA2065965A1 (fr)	1992-10-18
AU648659B2 (en)	1994-04-28
CY2146B1 (en)	2002-06-21
EP0509752A2 (fr)	1992-10-21
EP0509752B1 (fr)	1999-08-04
CN1066781A (zh)	1992-12-09
DK0509752T3 (da)	1999-12-06
LU90506I2 (fr)	2000-03-28
CZ285129B6 (cs)	1999-05-12
NO933714D0 (no)	1993-10-15
IE921240A1 (en)	1992-10-21

Publication	Publication Date	Title
EP0253094A3 (en)	1990-08-22	Use of prostaglandin d2-active substances in the treatment of ocular hypertension and glaucoma
CH0509752H1 (fr)	2012-11-30
DE69418947D1 (de)	1999-07-15	Stilbenderivate und analoga sowie deren anwendung
EP0276543A3 (fr)	1989-08-30	Emploi de buspirone pour l'amélioration de la mémoire à court terme
AU9064991A (en)	1992-07-08	Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
ITMI911998A1 (it)	1993-01-18	Dispositivo abradente agglomerato particolarmente per burattatura e simili nonche' procedimento realizzativo.
WO1994006345A3 (en)	1995-01-19	Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof
ITRM940160A0 (it)	1994-03-23	Procedimento e dispositivo per la riduzione dell'inserimento di ossigeno in un monocristallo di silicio.
GR3015107T3 (en)	1995-05-31	Use of zofenopril for the preparation of drugs against rheumatoid arthritis.
AU7755591A (en)	1991-11-11	The use of synthetic metalloporphyrins in the treatment of hypertension and other vascular disorders
ZA9210003B (en)	1994-01-13	The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjects
ITMI910913U1 (it)	1993-04-21	Portaombrelli portatile, in particolare per l'utilizzo all'interno di autovetture
KR950012439U (ko)	1995-05-17	브이씨알의 소비 전력 저감 장치
IT1225800B (it)	1990-12-06	Polarizzatore doppio, per l'osservazione dei cinescopi in genere
IT8847948A0 (it)	1988-05-11	Dispositivo per l'erogazione di gas narcotico, incorporato in aerei di linea e simili. a fini antiterroristici
ES1023451Y (es)	1994-02-01	"almohada inflable de uso personal".
FR2706106B1 (fr)	1995-09-01	Dispositif portable de communication interactive en mode graphique à l'usage des déficients oraux et/ou auditifs sévères.
ITRM920698A0 (it)	1992-09-24	Dispositivo di facilitazione all'accesso ai letti di navi, traghetti e simili, per inabili
SE8800530D0 (sv)	1988-02-17	"livreddaren", anordning vid fordon i trafik
ITMI920408V0 (it)	1992-04-22	Borraccia doppia per ciclisti e simili
IT9021076A0 (it)	1990-07-26	"nuovo uso del bendazac e dei suoi sali farmaceuticamente accettabili"
ITMI920230U1 (it)	1993-09-12	Dispositivo per il sostegno e per l'azionamento meccanizzato di accend ini tascabili e simili, particolarmente per impieghi anche prolungati in condizione di sicurezza
ITFI950075V0 (it)	1995-07-26	Supporto per pallina utilizzabile per l'esercizio del coordinamento dei movimenti e/o per passatempo
LT2352B (lt)	1993-12-15	Restriktazes,atpazistancios ir skeliancios nukleotidu seka 5'=c ggccg, gavimo budas